San Francisco, (January 13, 2020) – Intrommune Therapeutics presented an update today on their oral mucosal immunotherapy (OMIT) technology at the Biotech Showcase™, which occurs during the annual J.P. Morgan Healthcare Conference. “We are very excited to provide investors an ...